Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 65 of 89 for:    CARBAMAZEPINE AND Psychotropic

Prediction of Childhood Epilepsy Outcome in Bangladesh

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00381537
Recruitment Status : Completed
First Posted : September 28, 2006
Last Update Posted : December 25, 2006
Information provided by:
Institute of Child Health

Brief Summary:
Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.

Condition or disease Intervention/treatment Phase
Epilepsy Drug: phenobarbitone Drug: carbamazepine Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 92 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Epilepsy

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Active epilepsy
  • Aged 2-15 years

Exclusion Criteria:

  • Excluded absence
  • Myoclonic and malignant epilepsy syndromes
  • Major motor and cognitive impairments
  • Those currently receiving antiepilepsy drugs.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00381537

Layout table for location information
Children’s Hospital Dhaka (Shishu) Bangladesh.
Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh
United Kingdom
Institute of Child Health
London, United Kingdom, WC1N 1EH
Sponsors and Collaborators
Institute of Child Health
Layout table for investigator information
Principal Investigator: Brian Neville, Professor Institute of Child Health
Principal Investigator: Selina Banu, Dr Children’s Hospital Dhaka (Shishu) Bangladesh.

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information Identifier: NCT00381537    
Other Study ID Numbers: 99NR58
First Posted: September 28, 2006    Key Record Dates
Last Update Posted: December 25, 2006
Last Verified: December 2006
Keywords provided by Institute of Child Health:
childhood epilepsy
Active childhood epilepsy
Additional relevant MeSH terms:
Layout table for MeSH terms
Psychotropic Drugs
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Antimanic Agents
Tranquilizing Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cytochrome P-450 CYP3A Inducers
Cytochrome P-450 Enzyme Inducers
Hypnotics and Sedatives
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
GABA Modulators
GABA Agents
Cytochrome P-450 CYP2B6 Inducers